Dexcom, Inc. 8-K Report: Key Insights & Stock Information for Investors

$DXCM
Form 8-K
Filed on: 2025-05-02
Source
Dexcom, Inc. 8-K Report: Key Insights & Stock Information for Investors

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Dexcom, Inc.
  • CIK (Central Index Key): 0001093557
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 000-51222
  • IRS Employer Identification Number: 33-0857544
  • Address: 6340 Sequence Drive, San Diego, CA 92121
  • Phone Number: 858-200-0200
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: May 1, 2025
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: DXCM
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: May 1, 2025
  • End Date: May 1, 2025

Summary Insights:

  • The report is a Form 8-K, which typically provides current reports of significant events that shareholders should know about.
  • Dexcom, Inc. is actively listed on the NASDAQ under the ticker DXCM.
  • The filing date aligns with the reporting period, suggesting that this is either a timely disclosure of a material event or a periodic update required by the SEC.

This information is crucial for investors, analysts, and stakeholders who track the company's performance and compliance with regulatory requirements.